RELY-Resection of colorectal liver metastases with or without routine hilar lymphadenectomy - A Randomized Controlled Trial

Not Applicable

Recruiting

• Conditions: colorectal liver metastases; Cancer - Liver; Cancer - Bowel - Back passage (rectum) or large bowel (colon)

• Registration Number: ACTRN12614001195640
• Lead Sponsor: Juergen Weitz, MD, MSc

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-11-13
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 224

Inclusion Criteria

Patients scheduled for resection of colorectal cancer liver metastases. Patients undergoing simultanous resection of the primary tumor together with liver metastases may also be enrolled in the trial
Patients scheduled for curative (R0) resection
No evidence of extrahepatic disease
No history of previous hilar lymphadenectomy
Age equal or greater than 18 years
Written Informed consent

Exclusion Criteria

Expected lack of compliance
Impaired mental state or language problems
History of another primary cancer, except:
Curatively treated in situ cervical cancer or curatively resected non-melanoma skin cancer
Other primary solid tumour curatively treated with no known active disease present and no treatment administered for up to 5 years prior to randomisation

Study & Design

• Study Type: Interventional
• Study Design: Not specified